A polygenic model of the metabolic syndrome with reduced circulating and intra-adipose glucocorticoid action

Diabetes

Volumn 54, Issue 12, 2005, Pages 3371-3378

  Morton, Nicholas M ^a,c   Densmore, Valerie ^a   Wamil, Malgorzata ^a   Ramage, Lynne ^a   Nichol, Katherine ^a   Bünger, Lutz ^b   Seckl, Jonathan R ^a   Kenyon, Christopher J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b SCOTTISH AGRICULTURAL COLLEGE   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTICOSTERONE; GLUCOCORTICOID;

ADIPOSE TISSUE CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT DISTRIBUTION; BODY WEIGHT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOSTERONE RELEASE; DISEASE EXACERBATION; FAT CONTENT; FATTY LIVER; FEMALE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC TRAIT; HORMONE BLOOD LEVEL; HYPERTENSION; INSULIN RESISTANCE; LEAN BODY WEIGHT; LIPID DIET; MALE; METABOLIC SYNDROME X; MORBID OBESITY; MULTIFACTORIAL INHERITANCE; NONHUMAN; PRIORITY JOURNAL;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; CORTICOSTERONE; CROSSES, GENETIC; CUSHING SYNDROME; EPIDIDYMIS; GLUCOCORTICOIDS; INSULIN; LEPTIN; LIVER; MALE; METABOLIC SYNDROME X; MICE; MICE, OBESE; MODELS, GENETIC; OBESITY; RNA; SKIN; TRIGLYCERIDES;

EID: 33644679335     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/diabetes.54.12.3371     Document Type: Article

References (45)

1. Flier JS: Obesity wars: molecular progress confronts an expanding epidemic. Cell 116:337-350, 2004
2. O'Rahilly S: Insights into obesity and insulin resistance from the study of extreme human phenotypes. Eur J Endocrinol 147:435-441, 2002
3. Damcott CM, Sack P, Shuldiner AR: The genetics of obesity. Endocrinol Metab Clin North Am 32:761-786, 2003
4. Peeke PM, Chrousos GP: Hypercortisolism and obesity. Ann N Y Acad Sci 771:665-676, 1995
5. Shimomura Y, Bray GA, Lee M: Adrenalectomy and steroid treatment in obese (ob/ob) and diabetic (db/db) mice. Horm Metab Res 19:295-299, 1987
6. MacDougald OA, Lane MD: Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem 64:345-373, 1995
7. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS: A transgenic model of visceral obesity and the metabolic syndrome. Science 294:2166-2170, 2001
8. Friedman JE, Sun Y, Ishizuka T, Farrell CJ, McCormack SE, Herron LM, Hakimi P, Lechner P, Yun JS: Phosphoenolpyruvate carboxykinase (GTP) gene transcription and hyperglycemia are regulated by glucocorticoids in genetically obese db/db transgenic mice. J Biol Chem 272:31475-31481, 1997
9. Paterson JM, Morton NM, Fievet C, Kenyon CJ, Holmes MC, Staels B, Seckl JR, Mullins JJ: Metabolic syndrome without obesity: hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc Natl Acad Sci U S A 101:7088-7093, 2004
10. Dimitriadis G, Leighton B, Parry-Billings M, Sasson S, Young M, Krause U, Bevan S, Piva T, Wegener G, Newsholme EA: Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle. Biochem J 321:707-712, 1997
11. Makimura H, Mizuno TM, Roberts J, Silverstein J, Beasley J, Mobbs CV: Adrenalectomy reverses obese phenotype and restores hypothalamic melanocortin tone in leptin-deficient ob/ob mice. Diabetes 49:1917-1923, 2000
12. Wake DJ, Walker BR: 11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome. Mol Cell Endocrinol 215:45-54, 2004
13. Rask E, Olsson T, Soderberg S, Andrew R, Livingstone DE, Johnson O, Walker BR: Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 86:1418-1421, 2001
14. Paulmyer-Lacroix O, Boullu S, Oliver C, Alessi MC, Grino M: Expression of the mRNA coding for 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study. J Clin Endocrinol Metab 87:2701-2705, 2002
15. Lindsay RS, Wake DJ, Nair S, Bunt J, Livingstone DE, Permana PA, Tataranni PA, Walker BR: Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. J Clin Endocrinol Metab 88:2738-2744, 2003
16. Livingstone DE, Kenyon CJ, Walker BR: Mechanisms of dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obese Zucker rats. J Endocrinol 167:533-539, 2000
17. Masuzaki H, Yamamoto H, Kenyon CJ, Elmquist JK, Morton NM, Paterson JM, Shinyama H, Sharp MG, Fleming S, Mullins JJ, Seckl JR, Flier JS: Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest 112:83-90, 2003
18. Johansson A, Andrew R, Forsberg H, Cederquist K, Walker BR, Olsson T: Glucocorticoid metabolism and adrenocortical reactivity to ACTH in myotonic dystrophy. J Clin Endocrinol Metab 86:4276-4283, 2001
19. Morton NM, Holmes MC, Fievet C, Staels B, Tailleux A, Mullins JJ, Seckl JR: Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice. J Biol Chem 276:41293-41300, 2001
20. Morton NM, Paterson JM, Masuzaki H, Holmes MC, Staels B, Fievet C, Walker BR, Flier JS, Mullins JJ, Seckl JR: Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11β-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 53:931-938, 2004
21. Alberts P, Nilsson C, Selen G, Engblom LO, Edling NH, Norling S, Klingstrom G, Larsson C, Forsgren M, Ashkzari M, Nilsson CE, Fiedler M, Bergqvist E, Ohman B, Bjorkstrand E, Abrahmsen LB: Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. Endocrinology 144:4755-4762, 2003
22. Bünger L, Hill WG: Inbred lines of mice derived from long-term divergent selection on fat content and body weight. Mamm Genome 10:645-648, 1999
23. Bünger L, Forsting J, McDonald KL, Horvat S, Duncan J, Hochscheid S, Baile CA, Hill WG, Speakman JR: Long-term divergent selection on fatness in mice indicates a regulation system independent of leptin production and reception. FASEB J 17:85-87, 2003
24. Horvat S, Bünger L, Falconer VM, Mackay P, Law A, Bulfield G, Keightley PD: Mapping of obesity QTLs in a cross between mouse lines divergently selected on fat content. Mamm Genome 11:2-7, 2000
25. Pihl L, Hau J: Faecal corticosterone and immunoglobulin A in young adult rats. Lab Anim 37:166-171, 2003
26. Evans AL, Brown W, Kenyon CJ, Maxted KJ, Smith DC: Improved system for measuring systolic blood pressure in the conscious rat. Med Biol Eng Comput 32:101-102, 1994
27. Trayhurn P, Thomas MEA, Duncan JS, Rayner DV: Effects of fasting and refeeding on ob gene expression in white adipose tissue of lean and obese ob/ob mice. FEBS Lett 368:488-490, 1995
28. Dagogo-Jack S, Selke G, Melson AK, Newcomer JW: Robust leptin secretory responses to dexamethasone in obese subjects. J Clin Endocrinol Metab 82:3230-3233, 1997
29. De Vos P, Saladin R, Auwerx J, Staels B: Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J Biol Chem 270:15958-15961, 1995
30. Haluzik M, Dietz KR, Kim JK, Marcus-Samuels B, Shulman GI, Gavrilova O, Reitman ML: Adrenalectomy improves diabetes in A-ZIP/F-1 lipoatrophic mice by increasing both liver and muscle insulin sensitivity. Diabetes 51:2113-2118, 2002
31. Morton NM, Ramage L, Seckl JR: Down-regulation of adipose 11betahydroxysteroid dehydrogenase type 1 by high-fat feeding in mice: a potential adaptive mechanism counteracting metabolic disease. Endocrinology 145:2707-2712, 2004
32. Stylianou IM, Clinton M, Keightley PD, Pritchard C, Tymowska-Lalanne Z, Bünger L, Horvat S: Microarray gene expression analysis of the Fob3b obesity QTL identifies positional candidate gene Sqle and perturbed cholesterol and glycolysis pathways. Physiol Genomics 20:224-232, 2005
33. Boden G: Obesity, free fatty acids, and insulin resistance. Curr Opin Endocrinol Diabetes 8:235-239, 2001
34. McLaughlin T, Allison G, Abbasi F, Lamendola C, Reaven G: Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals. Metabolism 53:495-499, 2004
35. Chen HC, Farese RV Jr: Fatty acids, triglycerides, and glucose metabolism: recent insights from knockout mice. Curr Opin Clin Nutr Metab Care 5:359-363, 2002
36. Challis BG, Coll AP, Yeo GS, Pinnock SB, Dickson SL, Thresher RR, Dixon J, Zahn D, Rochford JJ, White A, Oliver RL, Millington G, Aparicio SA, Colledge WH, Russ AP, Carlton MB, O'Rahilly S: Mice lacking proopiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36). Proc Natl Acad Sci U S A 101:4695-700, 2004
37. Boswell T, Nicholson MA, Bünger L: Neuropeptide Y gene expression in lines of mice subjected to long-term divergent selection on fat content. J Mol Endocrinol 23:77-83, 1999
38. Pepin MC, Pothier F, Barden N: Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene. Nature 355:725-728, 1992
39. Barzilai N, She L, Liu BQ, Vuguin P, Cohen P, Wang J, Rossetti L: Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes 48:94-98, 1999
40. Goldstone AP, Thomas EL, Brynes AE, Bell JD, Frost G, Saeed N, Hajnal JV, Howard JK, Holland A, Bloom SR: Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi female adults: evidence for novel influences on body fat distribution. J Clin Endocrinol Metab 86:4330-4338, 2001
41. Nair S, Lee YH, Lindsay RS, Walker BR, Tataranni PA, Bogardus C, Baier LJ, Permana PA: 11beta-hydroxysteroid dehydrogenase type 1: genetic polymorphisms are associated with type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle. Diabetologia 47:1088-1095, 2004
42. Jamieson PM, Chapman KE, Edwards CR, Seckl JR: 11 beta-hydroxysteroid dehydrogenase is an exclusive 11 beta-reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations. Endocrinology 136:4754-4761, 1995
43. Sowers JR: Insulin resistance and hypertension. Am J Physiol Heart Circ Physiol 286:597-602, 2004
44. Tomlinson JW, Sinha B, Bujalska I, Hewison M, Stewart PM: Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity. J Clin Endocrinol Metab 87:5630-5635, 2002
45. Walker BR, Connacher AA, Lindsay RM, Webb DJ, Edwards CR: Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. J Clin Endocrinol Metab 80:3155-3159, 1995